• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Trump ends Biden’s drug price nightmare — Americans get real relief with TrumpRx

by March 11, 2026
written by March 11, 2026

As a physician and a mother, I have seen firsthand how Washington’s decisions ripple into the exam room and around the kitchen table. At a time when healthcare debates often divide, it is worth recognizing leaders who safeguard freedom while tackling real health needs. The Trump administration is doing exactly that: protecting access, preserving choice and confronting public-health challenges while trusting families and their physicians to decide what is best.

President Donald Trump is proving that when Washington listens to everyday Americans and acts with urgency, real change is possible. For too long, the crushing cost of prescription drugs has forced families to make an impossible choice between filling a prescription and paying their bills.

Lowering drug prices has been a cornerstone of his presidency, and he has taken meaningful steps to deliver by expanding generics and biosimilars, implementing historic price transparency rules, capping insulin costs for seniors, advancing TrumpRX to increase competition to increase competition and direct access, and pursuing a ‘Most Favored Nation’ policy, so Americans are no longer paying more for medications than patients in other developed countries.

These policies represent an important shift toward putting patients, not middlemen, first. It’s a strong and necessary start, but sustaining this momentum by increasing competition and expanding access will be critical to finally bringing lasting relief to Americans.

This is not the first time Trump has revolutionized healthcare access. He set the tone during his first term with Operation Warp Speed, a milestone in American biomedical history, after COVID-19 paralyzed the world six years ago this month. By pairing private‑sector innovation with decisive federal coordination, it accelerated effective vaccine development and distribution; proving speed and rigor can coexist when government clears paths instead of creating bottlenecks. Just as important, it expanded options for patients and families, reinforcing a simple principle: access first, always.

What followed, however, is where public trust began to erode. Not because of Operation Warp Speed, but because its success was taken over by bureaucratic overreach. I watched in real time as public trust in health institutions collapsed, common sense was dismissed, legitimate debate was shut down and universal COVID vaccine mandates were imposed. Patients did not turn away from the vaccine recommendations because of the science; they turned away because of coercion despite evolving science and varying risk levels.

When personal autonomy gave way to mandates, they undermined confidence in both institutions and vaccines themselves. The result wasn’t the product of Trump’s leadership and scientific progress; it was the consequence of power being prioritized over personal choice.

Today, this administration is again pursuing strong public‑health outcomes without treating Americans as bystanders. Trust should be built where it matters most: in the home and in the doctor’s office. Parents want choice. Doctors want access. Parents overwhelmingly trust their own physicians. Doctors who know a child’s history and needs should remain the most trusted voices and, increasingly, America’s health agencies are speaking that same language.

The recent shift in tone from top health leaders is significant and worth recognizing. Acting Centers for Disease Control and Prevention Director Jay Bhattacharya is urging Americans to get the measles vaccine as cases rise and the U.S. risks losing its hard-won elimination status. He called the decision ‘deeply personal’ while making clear that ‘measles is preventable and vaccination remains the most effective way to protect yourself and those around you.’

Centers for Medicare & Medicaid Services Administrator Mehmet Oz echoed that in February: ‘There will never be a barrier to Americans getting access to the measles vaccine. It is part of the core schedule.’ This is what responsible public health communication looks like: honest, direct, and rooted in science, without coercion.

President Donald Trump is proving that when Washington listens to everyday Americans and acts with urgency, real change is possible.

The challenge now is sustaining this posture. Keeping vaccines available, affordable and accessible is not a concession to one side of the political debate, it’s broadly popular across the spectrum and conservatives are no exception. Skepticism of mandates and top-down health edicts does not translate into a desire to see vaccines become harder to get or more expensive to access. Americans want the freedom to make their own choices alongside their doctors and that freedom is only meaningful when access is guaranteed.

At the same time, the message must be clear: removing mandates does not mean vaccines are no longer recommended, or they have somehow been deemed unsafe. Vaccines remain one of the most effective tools in modern medicine. When vaccination rates fall, history and modern-day show that preventable disease and mortality rise.

Trump understands this, and his agencies need to hold the line: speak honestly about what the science says, respect personal decision-making and ensure that no American faces a barrier to a vaccine they want. That’s a winning posture politically — and more importantly, it’s the right thing to do.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
The US government targeted me for my political speech. It could happen to you, too
next post
Dow Jones futures today: investors brace for US CPI amid war uncertainty

related articles

Trump’s apocalyptic Iran warning raises stakes for sweeping...

April 7, 2026

Graham eyes ‘down payment’ on Trump-backed SAVE Act...

April 7, 2026

Democrat whose parents fled Iran moves to oust...

April 7, 2026

Midterm alarm bells: Democrats face steep favorability deficit...

April 7, 2026

American journalist kidnapped in Iraq is set free,...

April 7, 2026

Dem Senate primary erupts in key state as...

April 7, 2026

Trump-backed candidate aims to pad GOP’s fragile House...

April 7, 2026

White House unleashes on Stacey Abrams in latest...

April 7, 2026

Ilhan Omar calls Trump an ‘unhinged lunatic,’ urges...

April 7, 2026

Former Virginia Gov Glenn Youngkin hints at political...

April 7, 2026
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • India’s economy looks strong with low inflation—but do people feel it

    January 11, 2026
  • Trump pushes to recover ‘billions of dollars’ of military equipment left behind in Afghanistan withdrawal

    February 26, 2025
  • How Nvidia chips were smuggled to China via Supermicro

    March 20, 2026
  • Marjorie Taylor Greene launches probe into Planned Parenthood’s use of taxpayer funds

    June 13, 2025
  • Trump gives Hamas 48 hours to return all deceased Gaza hostages, or ‘other countries will take action’

    October 26, 2025

Popular Posts

  • 1

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025
  • 2

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 3

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 4

    CoreWeave eyes $1.5B bond raise to ease debt load following lacklustre IPO: report

    May 9, 2025
  • 5

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024

Categories

  • Economy (829)
  • Editor's Pick (8,502)
  • Investing (1,923)
  • Stock (1,017)

Latest Posts

  • JPMorgan Chase is opening more small-town branches in middle America

    August 6, 2024
  • Nifty continues to make new all-time highs this week as well

    September 3, 2024
  • JONATHAN TURLEY: End NPR’s taxpayer-funded gravy train

    February 2, 2025

Recent Posts

  • Dollar stores are struggling to win over bargain hunters — here’s why

    December 4, 2024
  • House Weaponization panel releases 17,000-page report exposing ‘two-tiered system of government’

    December 20, 2024
  • JetBlue to partner with another U.S. airline in the coming weeks

    April 30, 2025

Editor’s Pick

  • MIKE DAVIS: Kash Patel is restoring the FBI despite constant attacks

    February 25, 2026
  • The great airlift: how Apple ferried 1.5M iPhones from India to the US to beat Trump tariffs

    April 10, 2025
  • Democrats demand subpoena for Lewandowski over controversial $220M DHS ad campaign

    March 26, 2026
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock